News & Analysis on Clinical Trial Services & Contract Research And Development
Specialty chemical company Avecia featured prominently at the recent CPhI Expo in Madrid, announcing investments and activity, which hint at the business of custom synthesis of APIs and advanced intermediates coming back into favour.
Catch-up legislation from the EU has swept away the handicap on European generics companies, allowing them to research copycat drugs before patent expiry.
Sigma-Aldrich Fine Chemicals (SAFC) Biosciences chose the CPhI Expo in Madrid to announce a series of updates concerning company activity. The custom manufacturing group is currently undergoing construction of a new US facility aimed at manufacturing...
German specialty chemicals group, H&R Wasag, increased its sales and earnings in the third quarter of this year, helped by its in-house refinery operations that allow it to counter the steady rise in costs arising from crude oil prices.